Fig. 1: Rapidly isolating and characterizing broadly protective antibodies.
From: Catching the breadth of broadly protective antibodies to SARS-CoV-2
A representation of the workflow used by He et al.1 to isolate and characterize antibodies that protect against SARS-CoV-2 VOCs and divergent sarbecoviruses. It begins with identifying donors most likely to harbor these antibodies and characterizing their antibodies to identify the most potent examples. This workflow can inform future clinical developments.
